* Announces a review of strategic alternatives
* Says strategic review not limited to a sale of the Co
* Says review was precipitated by receipt of expression of interest by un-named
pharmaceutical company
* Says has engaged Desjardins securities as financial advisor to assist it
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
MMMM

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index